HIGHLIGHTS
- who: Naomi Hayashi from the (UNIVERSITY) have published the paper: Evaluation of an inflammation-based score for identification of appropriate patients for comprehensive genomic profiling, in the Journal: (JOURNAL) of 31/Dec/2021
- what: The aim of patients undergoing CGP is to have rapid access to molecular targeted therapy. On the basis of this analysis, the cut-off value for CRP was calculated to be 0.45 mg/dl (sensitivity 69.1%, specificity 59.8%). The study showed that patients with mGPS 2 had a poor prognosis. Discover Oncology | https://doi.org/10.1007/s12672 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.